Published in a special European Respiratory Society issue of The Lancet, two new genetic variants or loci that increase susceptibility to asthma have been identified in an international investigation. These discoveries add to the evidence that genes connected with signaling molecules (cytokines) involved in the functioning of the immune system are linked with the development of asthma. This indicates that a medication which is used currently to treat rheumatoid arthritis (RA) might be successful to treat asthma.

Although there have been several attempts to detect the specific genetic mechanisms responsible for asthma, the causes are not very well understood. Several candidate genes have been identified in recent genome-wide association studies (GWAS), that have a moderate effect on the risk of asthma, however, this only explains a small segment of the disease heritability indicating that several more genetic variations have yet to be identified.

Expanding and combining existing asthma GWAS was carried out by Manuel Ferreira from the Queensland Institute of Medical Research, Brisbane, Australia, who led an international team, In order to try and identify new genetic variations responsible for increasing the risk of asthma. When they compared the genomes of thousands of patients with asthma with genomes of individuals who didn't have asthma across several populations, they discovered two new genetic variants with a strong link with asthma risk, rs4129267 in the interleukin-6 receptor (IL6R) gene and rs7130588 on chromosome 11q13.5.

Interleukin 6 (IL-6) is a cytokine that plays a crucial role in immunity and inflammation, and is involved in the pathogenesis of several diseases including rheumatoid arthritis. The rs4129267 risk variant increases the expression of the IL-6 receptor and therefore the researchers propose that medications that block the receptor, such as tocilizumab which for RA is already licensed for treatment, should be taken into consideration for clinical trials in order to prevent or reduce the airway inflammation linked with asthma.

The rs7130588 variant on chromosome 11q13.5 was discovered to be more common in asthma patients who are atopic (allergic), and was connected with a close variant which was recently associated with atopic dermatitis. Indicating that a gene in this area has an important role in the development of allergic sensitization, which increases the following risk of developing allergic asthma. The researchers explain:

"At this stage it is unclear which gene underlies the association with 11q13.5. Given that no specific gene in this region has been directly implicated in allergic disease previously, further characterization of this region of association is likely to discover novel molecular mechanisms involved in the causality of eczema, atopy, and asthma."


Up until now, not one genetic cause has been identified that accounts for over 1% of asthma heritability. Results from this investigation verify that the disease is complex, with potentially numerous genes of small effect each combining and interacting with environmental risk factors to effect whether an individual is likely to develop asthma.

They conclude:

"Our results are consistent with the contribution of hundreds or potentially thousands of variants with weak effects on asthma risk, which can be identified through larger GWAS as already shown with other diseases."


Talking about the pros and cons of GWAS design, Kathleen Barnes from Johns Hopkins University, Baltimore, USA, comments:

"Success in the validation of various candidates (and their pathways) that are already on the asthma shortlist of potential causal genes, and the biological insight to be gained from the novel findings in this report are grounds for optimism in the continuation of the GWAS approach. Combination of GWAS with next-generation technologies will undoubtedly further help to disentangle the molecular underpinnings of complex traits such as asthma."


Written by Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

Published in a special European Respiratory Society issue of The Lancet, two new genetic variants or loci that increase susceptibility to asthma have been identified in an international investigation. These discoveries add to the evidence that genes connected with signaling molecules (cytokines) involved in the functioning of the immune system are linked with the development of asthma. This indicates that a medication which is used currently to treat rheumatoid arthritis (RA) might be successful to treat asthma.

Although there have been several attempts to detect the specific genetic mechanisms responsible for asthma, the causes are not very well understood. Several candidate genes have been identified in recent genome-wide association studies (GWAS), that have a moderate effect on the risk of asthma, however, this only explains a small segment of the disease heritability indicating that several more genetic variations have yet to be identified.

Expanding and combining existing asthma GWAS was carried out by Manuel Ferreira from the Queensland Institute of Medical Research, Brisbane, Australia, who led an international team, In order to try and identify new genetic variations responsible for increasing the risk of asthma. When they compared the genomes of thousands of patients with asthma with genomes of individuals who didn't have asthma across several populations, they discovered two new genetic variants with a strong link with asthma risk, rs4129267 in the interleukin-6 receptor (IL6R) gene and rs7130588 on chromosome 11q13.5.

Interleukin 6 (IL-6) is a cytokine that plays a crucial role in immunity and inflammation, and is involved in the pathogenesis of several diseases including rheumatoid arthritis. The rs4129267 risk variant increases the expression of the IL-6 receptor and therefore the researchers propose that medications that block the receptor, such as tocilizumab which for RA is already licensed for treatment, should be taken into consideration for clinical trials in order to prevent or reduce the airway inflammation linked with asthma.

The rs7130588 variant on chromosome 11q13.5 was discovered to be more common in asthma patients who are atopic (allergic), and was connected with a close variant which was recently associated with atopic dermatitis. Indicating that a gene in this area has an important role in the development of allergic sensitization, which increases the following risk of developing allergic asthma. The researchers explain:

"At this stage it is unclear which gene underlies the association with 11q13.5. Given that no specific gene in this region has been directly implicated in allergic disease previously, further characterization of this region of association is likely to discover novel molecular mechanisms involved in the causality of eczema, atopy, and asthma."


Up until now, not one genetic cause has been identified that accounts for over 1% of asthma heritability. Results from this investigation verify that the disease is complex, with potentially numerous genes of small effect each combining and interacting with environmental risk factors to effect whether an individual is likely to develop asthma.

They conclude:

"Our results are consistent with the contribution of hundreds or potentially thousands of variants with weak effects on asthma risk, which can be identified through larger GWAS as already shown with other diseases."


Talking about the pros and cons of GWAS design, Kathleen Barnes from Johns Hopkins University, Baltimore, USA, comments:

"Success in the validation of various candidates (and their pathways) that are already on the asthma shortlist of potential causal genes, and the biological insight to be gained from the novel findings in this report are grounds for optimism in the continuation of the GWAS approach. Combination of GWAS with next-generation technologies will undoubtedly further help to disentangle the molecular underpinnings of complex traits such as asthma."


Written by Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations
. When she died, she left me the painting and it hangs in a place of honor over my fireplace mantle. It is done in enamel. I saw a painting he did of a fishing scene but I chose not to buy it. It's pretty funny to me that when we were growing up, she'd cry because she wasn't allowed to play football with us. If she could kick the ball they way she liked to kick me in the knee, I'd see to it she played for my team every time. I personally don't have any of these in my collection, since I like to collect pieces that I can relate to.My sister also shares my love for folk art.One of my favorite paintings was done in 1962 by Bill Dodge. I spent a lot of time with my grandmother and her house was full of them.I have loved folk art paintings that depict the world of black Americans. It's called Alligator Fisher and I'm thinking about getting because it reminds me of my cajun heritage, most of my family is from Louisiana. Now we're very close.One of the most famous American artists is.....

When they compared the genomes of thousands of patients with asthma with genomes of individuals who didn't have asthma across several populations, they discovered two new genetic variants with a strong link with asthma risk, rs4129267 in the interleukin-6 receptor (IL6R) gene and rs7130588 on chromosome 11q13. Although there have been several attempts to detect the specific genetic mechanisms responsible for asthma, the causes are not very well understood."Up until now, not one genetic cause has been identified that accounts for over 1% of asthma heritability. Interleukin 6 (IL-6) is a cytokine that plays a crucial role in immunity and inflammation, and is involved in the pathogenesis of several diseases including rheumatoid arthritis. Expanding and combining existing asthma GWAS was carried out by Manuel Ferreira from the Queensland Institute of Medical Research, Brisbane, Australia, who led an international team, In order to try and identify new genetic variations responsible for increasing the risk of asthma.5 was discovered to be more common in asthma patients who are atopic (allergic), and was connected with a close variant which was recently associated with atopic dermatitis."Talking about the pros and cons of GWAS design, Kathleen Barnes from Johns Hopkins University, Baltimore, USA, comments: "Success in the validation of various candidates (and their pathways) that are already on the asthma shortlist of potential causal genes, and the biological insight to be gained from the novel findings in this report are grounds for optimism in the continuation of the GWAS approach. Combination of GWAS with next-generation technologies will undoubtedly further help to disentangle the molecular underpinnings of complex traits such as asthma.5. Given that no specific gene in this region has been directly implicated in allergic disease previously, further characterization of this region of association is likely to discover novel molecular mechanisms involved in the I personally don't have any of these in my collection, since I like to collect pieces that I can relate to.One of the most famous American artists is Thomas Chambers.One of my favorite paintings was done in 1962 by Bill Dodge. I spent a lot of time playing in my tree house, that the trees in the picture appealed to me so much. Still, they are a joy to behold.The painting that has touched me the most features a sad little girl and is called A Letter From My Mother. Now we're very close. I don't know whose smile is bigger, the one in the painting or the one on my face every time I look at it.Another painting that I admire is called Howard in 1944.There is a subcategory of folk art paintings that depict the world of black Americans. It's called Alligator Fisher and I'm thinking about getting because it reminds me of my cajun heritage, most of my family is from Louisiana.I have loved folk art paintings since I was a child.. One of my favorites that she had was done by John Roeder.There is a water scene that I really like painted in 1940. I have a friend who collects these and I found one of a woman reclining in a hammock.My sister also shares my love for folk art. It was painted in 1988 by Reverend Howard Finster and is done in enamel. She favors animal prints, and I found one that depicts leopards and gave it to her for her birthday. It's pretty funny to me that when we were growing up, she'd cry because she wasn't allowed to play football with the boys and I used to tease her relentlessly and pull her pigtails whenever

rthritis society athritis society arhritis society artritis society arthitis society arthrtis society arthriis society arthrits society arthriti society arthritis ociety arthritis sciety arthritis soiety arthritis socety arthritis socity arthritis sociey arthritis societ srthritis society aethritis society atthritis society arrhritis society aryhritis society artgritis society artjritis society artheitis society arthtitis society arthrutis society arthrotis society arthriris society arthriyis society arthritus society arthritos society arthritia society arthritid society arthritis aociety arthritis dociety arthritis siciety arthritis spciety arthritis soxiety arthritis soviety arthritis socuety arthritis socoety arthritis sociwty arthritis socirty arthritis sociery arthritis socieyy arthritis societt arthritis societu rathritis society atrhritis society arhtritis society artrhitis society arthirtis society arthrtiis society arthriits society arthritsi society arthriti ssociety arthritis osciety arthritis scoiety arthritis soicety arthritis soceity arthritis socitey arthritis socieyt arthritis societ aarthritis society arrthritis society artthritis society arthhritis society arthrritis society arthriitis society arthrittis society arthritiis society arthritiss society arthritis ssociety arthritis soociety arthritis socciety arthritis sociiety arthritis socieety arthritis societty arthritis societyy
Published in a special European Respiratory Society issue of The Lancet, two new genetic variants or loci that increase susceptibility to asthma have been identified in an international investigation. These discoveries add to the evidence that genes connected with signaling molecules (cytokines) involved in the functioning of the immune system are linked with the development of asthma. This indicates that a medication which is used currently to treat rheumatoid arthritis (RA) might be successful to treat asthma.

Although there have been several attempts to detect the specific genetic mechanisms responsible for asthma, the causes are not very well understood. Several candidate genes have been identified in recent genome-wide association studies (GWAS), that have a moderate effect on the risk of asthma, however, this only explains a small segment of the disease heritability indicating that several more genetic variations have yet to be identified.

Expanding and combining existing asthma GWAS was carried out by Manuel Ferreira from the Queensland Institute of Medical Research, Brisbane, Australia, who led an international team, In order to try and identify new genetic variations responsible for increasing the risk of asthma. When they compared the genomes of thousands of patients with asthma with genomes of individuals who didn't have asthma across several populations, they discovered two new genetic variants with a strong link with asthma risk, rs4129267 in the interleukin-6 receptor (IL6R) gene and rs7130588 on chromosome 11q13.5.

Interleukin 6 (IL-6) is a cytokine that plays a crucial role in immunity and inflammation, and is involved in the pathogenesis of several diseases including rheumatoid arthritis. The rs4129267 risk variant increases the expression of the IL-6 receptor and therefore the researchers propose that medications that block the receptor, such as tocilizumab which for RA is already licensed for treatment, should be taken into consideration for clinical trials in order to prevent or reduce the airway inflammation linked with asthma.

The rs7130588 variant on chromosome 11q13.5 was discovered to be more common in asthma patients who are atopic (allergic), and was connected with a close variant which was recently associated with atopic dermatitis. Indicating that a gene in this area has an important role in the development of allergic sensitization, which increases the following risk of developing allergic asthma. The researchers explain:

"At this stage it is unclear which gene underlies the association with 11q13.5. Given that no specific gene in this region has been directly implicated in allergic disease previously, further characterization of this region of association is likely to discover novel molecular mechanisms involved in the causality of eczema, atopy, and asthma."


Up until now, not one genetic cause has been identified that accounts for over 1% of asthma heritability. Results from this investigation verify that the disease is complex, with potentially numerous genes of small effect each combining and interacting with environmental risk factors to effect whether an individual is likely to develop asthma.

They conclude:

"Our results are consistent with the contribution of hundreds or potentially thousands of variants with weak effects on asthma risk, which can be identified through larger GWAS as already shown with other diseases."


Talking about the pros and cons of GWAS design, Kathleen Barnes from Johns Hopkins University, Baltimore, USA, comments:

"Success in the validation of various candidates (and their pathways) that are already on the asthma shortlist of potential causal genes, and the biological insight to be gained from the novel findings in this report are grounds for optimism in the continuation of the GWAS approach. Combination of GWAS with next-generation technologies will undoubtedly further help to disentangle the molecular underpinnings of complex traits such as asthma."


Written by Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

Published in a special European Respiratory Society issue of The Lancet, two new genetic variants or loci that increase susceptibility to asthma have been identified in an international investigation. These discoveries add to the evidence that genes connected with signaling molecules (cytokines) involved in the functioning of the immune system are linked with the development of asthma. This indicates that a medication which is used currently to treat rheumatoid arthritis (RA) might be successful to treat asthma.

Although there have been several attempts to detect the specific genetic mechanisms responsible for asthma, the causes are not very well understood. Several candidate genes have been identified in recent genome-wide association studies (GWAS), that have a moderate effect on the risk of asthma, however, this only explains a small segment of the disease heritability indicating that several more genetic variations have yet to be identified.

Expanding and combining existing asthma GWAS was carried out by Manuel Ferreira from the Queensland Institute of Medical Research, Brisbane, Australia, who led an international team, In order to try and identify new genetic variations responsible for increasing the risk of asthma. When they compared the genomes of thousands of patients with asthma with genomes of individuals who didn't have asthma across several populations, they discovered two new genetic variants with a strong link with asthma risk, rs4129267 in the interleukin-6 receptor (IL6R) gene and rs7130588 on chromosome 11q13.5.

Interleukin 6 (IL-6) is a cytokine that plays a crucial role in immunity and inflammation, and is involved in the pathogenesis of several diseases including rheumatoid arthritis. The rs4129267 risk variant increases the expression of the IL-6 receptor and therefore the researchers propose that medications that block the receptor, such as tocilizumab which for RA is already licensed for treatment, should be taken into consideration for clinical trials in order to prevent or reduce the airway inflammation linked with asthma.

The rs7130588 variant on chromosome 11q13.5 was discovered to be more common in asthma patients who are atopic (allergic), and was connected with a close variant which was recently associated with atopic dermatitis. Indicating that a gene in this area has an important role in the development of allergic sensitization, which increases the following risk of developing allergic asthma. The researchers explain:

"At this stage it is unclear which gene underlies the association with 11q13.5. Given that no specific gene in this region has been directly implicated in allergic disease previously, further characterization of this region of association is likely to discover novel molecular mechanisms involved in the causality of eczema, atopy, and asthma."


Up until now, not one genetic cause has been identified that accounts for over 1% of asthma heritability. Results from this investigation verify that the disease is complex, with potentially numerous genes of small effect each combining and interacting with environmental risk factors to effect whether an individual is likely to develop asthma.

They conclude:

"Our results are consistent with the contribution of hundreds or potentially thousands of variants with weak effects on asthma risk, which can be identified through larger GWAS as already shown with other diseases."


Talking about the pros and cons of GWAS design, Kathleen Barnes from Johns Hopkins University, Baltimore, USA, comments:

"Success in the validation of various candidates (and their pathways) that are already on the asthma shortlist of potential causal genes, and the biological insight to be gained from the novel findings in this report are grounds for optimism in the continuation of the GWAS approach. Combination of GWAS with next-generation technologies will undoubtedly further help to disentangle the molecular underpinnings of complex traits such as asthma."


Written by Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations